Humacyte
(NASDAQ) HUMA
Humacyte Financials at a Glance
Market Cap
$151.10M
Revenue (TTM)
$8.80M
Net Income (TTM)
$36.97M
EPS (TTM)
$-0.24
P/E Ratio
-3.28
Dividend
$0.00
Beta (Volatility)
1.59 (High)
Dividend
$0.00
Beta (Volatility)
1.59 (High)
Price
$0.78
Volume
372,517
Open
$0.89
Price
$0.78
Volume
372,517
Open
$0.89
Previous Close
$0.78
Daily Range
$0.70 - $0.89
52-Week Range
$0.70 - $3.36
Dividend
$0.00
Beta (Volatility)
1.59 (High)
Price
$0.78
Volume
372,517
Open
$0.89
Previous Close
$0.78
Daily Range
$0.70 - $0.89
52-Week Range
$0.70 - $3.36
HUMA News
HUMA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Humacyte
Industry
Biotechnology
Sector
Health CareEmployees
220
CEO
Laura E. Niklason, MD, PhD
Website
humacyte.comHeadquarters
Durham, NC 27713, US
HUMA Financials
Key Financial Metrics (TTM)
Gross Margin
10%
Operating Margin
-12%
Net Income Margin
-4%
Return on Equity
-257%
Return on Capital
-2%
Return on Assets
-40%
Earnings Yield
-30.49%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$151.10M
Shares Outstanding
193.00M
Volume
372.52K
Short Interest
0.00%
Avg. Volume
6.40M
Financials (TTM)
Gross Profit
$7.19M
Operating Income
$114.40M
EBITDA
$132.23M
Operating Cash Flow
$98.12M
Capital Expenditure
$1.57M
Free Cash Flow
$99.69M
Cash & ST Invst.
$44.94M
Total Debt
$16.54M
Humacyte Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$753.00K
N/A
Gross Profit
$493.00K
+127.2%
Gross Margin
65.47%
N/A
Market Cap
$151.10M
N/A
Market Cap/Employee
$693.11K
N/A
Employees
218
N/A
Net Income
$17.51M
+55.3%
EBITDA
$13.03M
+62.7%
Quarterly Fundamentals
Net Cash
$10.34M
-412.9%
Accounts Receivable
$1.08M
N/A
Inventory
$18.42M
N/A
Long Term Debt
$44.83M
+211.8%
Short Term Debt
$2.67M
-7.5%
Return on Assets
-40.40%
N/A
Return on Invested Capital
-1.60%
N/A
Free Cash Flow
$23.95M
-0.5%
Operating Cash Flow
$23.90M
-4.4%